Cargando…
Efficacy and Safety of Multiple Sclerosis Drugs Approved Since 2018 and Future Developments
Multiple sclerosis treatment made substantial headway during the last two decades with the implementation of therapeutics with new modes of action and routes of application. We are now in the situation that second-generation molecules, approved since 2018, are on the market, characterized by reduced...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9307218/ https://www.ncbi.nlm.nih.gov/pubmed/35869335 http://dx.doi.org/10.1007/s40263-022-00939-9 |